Introduction
At least two previous works assessing solely renal length as a measure for compensatory growth of a single functioning kidney and demonstrated statistically significant differences in comparison to a normal kidney. therefore I think the statement this is not a sensitive marker for intrauterine changes is not accurate.
Population
Both abnormalities in fetal growth dealt in the paper (FGR and LGA) are commonly encountered during the third trimester -therefore it would be interesting to report patients who "crossed" from the control group to the study group.
Ultrasound examinations
Measurements -although I think the research question is important, and may yield data will clinical relevance to pre-and postnatal care of FGR cases, unless a dilatation of the renal pelvis is present, the measurements presented as "parenchymal thickness" are actually those performed for renal measurements during customary prenatal ultrasound (+/-1-2 mm of renal pelvis) i.e. renal width. Please comment. Please explain why measurements of MCA will be performed only > 30 weeks of gestation. Cases of early FGR (which present most hypertensive and metabolic disorders later in life) may demonstrate brain sparing and abnormal CPR earlier than 30 weeks of gestation. Moreover, in this group, Doppler indices of the uterine arteries should be measured. Is any follow up of the renal function of the children planned to correlate prenatal imaging findings and clinical status? 
REVIEWER

GENERAL COMMENTS
This is an interesting paper describing a prospective protocol to study fetal renal development by comprehensive ultrasound assessments of the fetal kidneys and fetal renal blood flow in pregnancies stratified by normally growing, growth restricted (IUGR) and large gestational age (LGA) fetuses. The presumption is that kidney growth in utero measured by fetal kidney length, kidney volume or, as proposed by this study, measures of renal parenchymal thickness may more accurately assess nephron number (i.e. nephron endowment) which, in turn, ultimately can predict an individual's kidney health for a lifetime. The primary and secondary objectives are well stated. The implicit hypothesis is that fetal renal parenchymal measurements predict nephron number. Appropriately in the Introduction, the authors concede that this can only be determined by autopsy studies. Nevertheless, this protocol is forward thinking in that it sets the stage for identification of at risk individuals from birth who can be followed prospectively for renal and cardiovascular health during early childhood.
Major Criticisms: 1. Should renal parenchymal area be referenced to fetal femoral length? 2. Is the generation R study included and appropriately referenced?
Minor Criticisms: 1. Abstract: "growth" should be "grown" 2. Page 3; line 4: "preventative" should be "preventive" 3. Page 8; line 5. Should it be "ductus venosus" not "venous" 4. Page 10; line 21: "de-identify" should be de-identified" Introduction At least two previous works assessing solely renal length as a measure for compensatory growth of a single functioning kidney and demonstrated statistically significant differences in comparison to a normal kidney. therefore I think the statement this is not a sensitive marker for intrauterine changes is not accurate.
Response Introduction -para 4, line 3 -the sentence has been reworded to -The most commonly reported ultrasound measurement was renal length; however, renal length alone was not found to be very sensitive to evaluate disruptions in fetal kidney growth in the presence of fetal growth restriction.
In a systematic review, we conducted, there were only two good studies since 1996 (both by Konje et al 1996 &1997) that used standard 2D methods to investigate fetal kidney growth in the setting of abnormal fetal growth. In growth restricted fetuses the antero-posterior (AP) and transverse (TS) dimensions were significantly decreased, but the kidney length remained similar to appropriately grown fetuses. No significant difference was demonstrated between the kidney lengths of growth restricted fetuses when compared to appropriately grown fetuses. The shape of the kidney changes and it appears long and skinny or "sausage-shaped" as described by Konje et al and suggests the thinning of the kidney could be due to fewer layers of nephrons. The systematic review excluded renal anomalies. A single functioning kidney is usually considered a renal anomaly and may not represent normal kidney development and growth. We are trying to determine subtle changes in fetal kidney growth when there are two kidneys, no fetal abnormality and abnormal fetal growth.
Reviewer 2 -Population Both abnormalities in fetal growth dealt in the paper (FGR and LGA) are commonly encountered during the third trimester -therefore it would be interesting to report patients who "crossed" from the control group to the study group.
Response
Participants will not be assigned to a group until after baby is born and all ultrasound and birth data are collected. They will then be divided into three groups: appropriate-for-gestational age, intrauterine growth restriction and large for gestational age.
Reviewer 2 -Ultrasound examinations Measurements -although I think the research question is important, and may yield data will clinical relevance to pre-and postnatal care of FGR cases, unless a dilatation of the renal pelvis is present, the measurements presented as "parenchymal thickness" are actually those performed for renal measurements during customary prenatal ultrasound (+/-1-2 mm of renal pelvis) i.e. renal width. Please comment.
Response Yes this comment true to an extent for fetuses with no renal dilatation, however there is a normal range of collecting system sizes. We are using parenchymal thickness measurements as a noninvasive proxy indicator of nephron number. Part of the reason we think it is important to measure only the parenchyma is that other 2D measurements such as length, width and height do include the entire kidney containing the parenchyma and collecting system. Therefore, if there is any hydronephrosis you will not get a true estimate of the thickness of the parenchyma. In a hydronephrotic kidney the 2D measurements, that include the collecting system, may indicate the kidney is normal in size or bigger than average however the parenchyma could be very thinned. We will develop normal ranges for parenchymal thickness which could be used in cases of hydronephrosis and other renal abnormalities to help assess nephron endowment.
Reviewer 2 -Please explain why measurements of MCA will be performed only > 30 weeks of gestation. Cases of early FGR (which present most hypertensive and metabolic disorders later in life) may demonstrate brain sparing and abnormal CPR earlier than 30 weeks of gestation. Moreover, in this group, Doppler indices of the uterine arteries should be measured.
Yes this is true. Under "Ultrasound examination" para 5, 3rd dot point -changed to • Middle cerebral artery Doppler (where clinically indicated or 30 weeks gestation and over). In our department MCA is routinely performed at 30 weeks gestation or later for all pregnancies. In any case < 30 weeks gestation where growth restriction is suspected and/or the umbilical artery doppler is abnormal then Doppler measurements of the MCA and uterine arteries are performed. It was extensively discussed if uterine artery Dopplers measures should be included in the study. As uterine artery Dopplers are mostly used as a predictive indicator to help identify fetuses that may be at risk of IUGR and participants were having to come for scans every 4 weeks or more, it was felt that this would add further to the length of the examination. Therefore, uterine artery doppler measurements were not included in this research project.
Reviewer 2 -Is any follow up of the renal function of the children planned to correlate prenatal imaging findings and clinical status?
Response As this research project is part of PhD studies there is a limit on the time and resources available to conduct the study. A separate research proposal and ethics application would be needed to perform ultrasound examinations and renal function tests on the infants. We have included in the consent form and ethics application consent to contact the parents after birth. We are planning to conduct another research project to follow-up the infants from the study and will be able to contact parents that were involved in this study. The authors have previously published renal parenchymal measurements in neonates.
Reviewer 
